Kaijie Zheng

Confined enzyme catalysis is a promising approach for pharmaceutical synthesis because it can combine high selectivity, catalytic efficiency and mild reaction conditions. This review examines recent advances in multiscale enzyme confinement for pharmaceutical applications, with emphasis on atomic-scale active-site regulation, molecular-scale immobilization and transport control and multi-enzyme cascade organization. We discuss how confined microenvironments modulate enzyme electronic states, conformational dynamics, substrate accessibility, local reaction conditions and intermediate transfer, thereby influencing catalytic activity, stability and stereoselectivity. Representative applications across major enzyme classes are discussed, with a focus on the synthesis of chiral drug intermediates and complex pharmaceutical molecules. The review also considers process-level sustainability, including process mass intensity (PMI) and the E-factor, together with limitations related to mass transfer, support preparation, long-term stability, scale-up and support material burdens. Overall, integrating multiscale confinement with spatially organized cascade catalysis offers a promising route toward more efficient and potentially more sustainable pharmaceutical manufacturing, although its net environmental benefit must be established through system-level assessment.

Traditional solid-contact ion-selective electrodes (SC-ISEs) are severely constrained by a long-standing thermodynamic bottleneck, which requires hours of pre-conditioning and stabilization to establish a stable phase-boundary potential. To fundamentally bypass this limitation, we present a paradigm shift in electrochemical ion sensing that exploits dynamic kinetics rather than waiting for thermodynamic equilibrium. In this paper, we report a transient potential profiling method that eliminates the need for equilibration by analyzing the open-circuit voltage decay during the first 60 s of polarization. A discharge step on indicator electrode returns the membrane to a reproducible initial state, allowing for the extraction of a concentration correlated coefficient. Using a calcium ISE with an optimized membrane, the early-stage polarization dynamics were fitted to a single exponential saturation model, predicting the steady state response with an average error of 1.6%. The method achieved high repeatability (intra-day RSD 3.22%), batch to batch reproducibility (4.57%), and recovery rates from 90.7% to 115.0% in real water samples. Validation against ion chromatography showed high agreement (R² = 0.997). This strategy enabled conditioning free, disposable ISEs for point of care and environmental monitoring.

Cancer cells predominantly utilize aerobic glycolysis for energy production, preferentially converting glucose (Glu) to pyruvate (PA) and subsequently to lactate (LA). This metabolic reprogramming results in extracellular LA accumulation, acidifying the tumor microenvironment (TME) and facilitating tumor invasion and metastasis. The dynamics of Glu, PA, and LA are pivotal to tumor initiation and progression. This review comprehensively discussed therapeutic strategies targeting these key metabolites and systematically evaluates electrochemical and fluorescence-based techniques for their dynamic monitoring. We highlight the critical role of these monitoring approaches in advancing early cancer diagnosis, enabling personalized treatment, and accelerating anticancer drug development.